Rottenstein Law Group Notes With Approval Facebook Decision to Withdraw Special Privileges From Drug

Rottenstein Law Group Notes With Approval Facebook Decision to Withdraw Special Privileges From Drugmakers The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of various prescription drugs, agrees with the decision of Facebook that drugmakers do not merit special treatment on the social networking site. (PRWEB) August 24, 2011 According to an article at DailyTech, Facebook has reversed an earlier policy decision to exempt the pages of pharmaceutical companies from public comments. Now those pages, like all others, will be open to all comme
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations